We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rejects Biosimilar Naming Petitions from GPhA, Sandoz; Approves J&J’s
FDA Rejects Biosimilar Naming Petitions from GPhA, Sandoz; Approves J&J’s
The FDA rejected two citizen petitions urging the agency to allow biosimilar sponsors to use the same nonproprietary names as their reference products, finding them incompatible with final guidance on the agency’s naming scheme published earlier this month.